The Effect of CORT118335 on Olanzapine-Induced Weight Gain

NCT03877562 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

96

Enrollment

INDUSTRY

Sponsor class

Conditions

Antipsychotic-induced Weight Gain

Interventions

DRUG: Olanzapine
DRUG: CORT118335
DRUG: Placebo

Sponsor

Corcept Therapeutics